1. Aricept US Package Insert, 1996. Roerig, Division of Pfizer, New York, NY.
2. Cognex US Package Insert, 1998. Parke-Davis, Division of Warner Lambert, Morris Plains, NJ.
3. Corey-Bloom, J., Anand, R., Veach, J., for the ENA 713 B352 Study Group, 1998. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int. J. Geriatr. Psychopharmacol. 1, 55–65.
4. Cholinergic drugs in Alzheimer's disease;Davis;N. Engl. J. Med.,1986
5. Brain Selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease;Enz,1993